A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved ODT formulation of a CGRP receptor antagonist in healthy adult participants under fasting conditions.
Epistemonikos ID: 8ecb0ed48b30435750719d8b986815f700de99db
First added on: May 19, 2026